Insider Stock Trading History of Onaitis Matthew


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Onaitis Matthew since year 2005. The trader's CIK number is 1362822. At the time of this reporting, Onaitis Matthew is the VP, General Counsel of Somaxon Pharmaceuticals, Inc. . (stock ticker symbol SOMX). See this page for all insider trading activities at Somaxon Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Onaitis Matthew since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-01-03 SOMX Somaxon Pharmaceuticals, Inc. Sale 9,000 .48 4,293
2010-12-01 SOMX Somaxon Pharmaceuticals, Inc. Sale 8,468 2.68 22,728
2010-03-18 SOMX Somaxon Pharmaceuticals, Inc. Sale 32,081 7.53 241,602
2010-03-18 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 29,454 1.23 36,228
2010-03-01 SOMX Somaxon Pharmaceuticals, Inc. Sale 30,000 4.02 120,480
2010-03-01 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 30,000 1.23 36,900
2010-02-05 SOMX Somaxon Pharmaceuticals, Inc. Sale 60,000 3.02 181,500
2010-02-05 SOMX Somaxon Pharmaceuticals, Inc. Option Ex 60,000 1.23 73,800
2009-12-31 SOMX Somaxon Pharmaceuticals, Inc. Sale 5,000 1.07 5,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Onaitis Matthew (VP, General Counsel of Somaxon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.